Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Boston Scientific’s Improving ICD Sales Offset Slow Stent Revenues In Q1

Apr 30 2007

Related Content

Boston Scientific Expects To Be Ready For FDA Inspections By Summer

Feb 05 2007

Medtronic Loses ICD Market Share, Looks Ahead To U.S. Market Rebound

Feb 26 2007

COURAGE Suggests Stents Do Not Benefit Stable Coronary Disease Patients

Apr 02 2007

More from Archive

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window